AI-driven, cloud-based system for real-time biomedical and pharmaceutical compliance and risk management

Abstract

An AI-driven, cloud-based system (100) for real-time biomedical and pharmaceutical compliance and risk management, including: (a) a compliance knowledge module configured to ingest, interpret and structure regulatory data using natural language processing (NLP) and generate machine-readable compliance rules; (b) a real-time monitoring and event recording module configured to collect and normalise operational data from distributed biomedical and pharmaceutical systems, including laboratory information management systems (LIMS), manufacturing execution systems (MES) and IoT-enabled devices; (c) an intelligent risk assessment and prediction module configured to correlate operational data with compliance rules, calculate dynamic risk scores and predict potential compliance violations using machine learning models; (d) an automated policy and workflow enforcement module configured to initiate remedial actions, assign tasks and log activities based on predefined standard operating procedures (SOPs); (e) an audit readiness and reporting module configured to generate compliance logs, audit trails and standardised regulatory reports in real time; and (f) an adaptive learning and feedback optimization module configured to refine rule sets and predictive models based on feedback, historical data and regulatory updates; g) the modules are integrated into a cloud infrastructure to enable real-time, scalable and predictive compliance and risk management across biomedical and pharmaceutical processes.

Description

[0001] The present invention relates to the field of artificial intelligence and cloud computing systems specifically designed for regulatory compliance and risk management in the biomedical and pharmaceutical sectors. It focuses on real-time monitoring, analysis, and enforcement of compliance protocols. The system ensures adherence to industry standards, mitigates operational risks, and streamlines audit readiness within companies.

[0002] In the highly regulated biomedical and pharmaceutical industries, companies must constantly comply with complex and evolving regulatory frameworks such as the FDA, EMA, HIPAA, and GxP. Manual compliance tracking, fragmented data storage, and siloed reporting processes frequently lead to delays, errors, and missed alerts—posing serious risks to patient safety, product approval deadlines, and the company's reputation. Traditional compliance management systems are often reactive and unable to provide real-time insights or predict potential compliance violations.

[0003] The complexity is further compounded by the global nature of pharmaceutical activities, which span multiple countries with varying regulations and standards. Existing solutions struggle to dynamically adapt to the changing compliance landscape, making it difficult for companies to maintain a consistent, centralized view of risk and compliance. Furthermore, the lack of integration across departments and disparate systems leads to incomplete or delayed data capture, limiting insight into key compliance metrics and increasing vulnerability to audits, penalties, and recalls.

[0004] To address these challenges, the invention proposes an AI-driven, cloud-based system that enables real-time monitoring, intelligent analytics, and proactive risk mitigation in biomedical and pharmaceutical operations. Leveraging machine learning, NLP, and knowledge graphs for compliance, the system automates the identification of patterns of non-compliance, delivers actionable insights, and integrates seamlessly with existing enterprise systems. This innovation transforms compliance from a reactive to a predictive model, reducing manual effort, improving decision-making, and ensuring compliance at all operational levels.

[0005] Another objective of the present disclosure is to reduce manual effort through automated policy enforcement workflows.

[0006] Another objective of this disclosure is to improve audit readiness with continuously updated compliance records.

[0007] Another objective of this disclosure is to predict regulatory risks using advanced AI and machine learning models.

[0008] Another objective of this disclosure is to adapt dynamically to changing global regulatory requirements.

[0009] Another goal of this disclosure is seamless integration into existing enterprise and cloud-based systems.

[0010] Another objective of this disclosure is to improve decision-making through intelligent risk assessment and analysis.

[0011] Another goal of this disclosure is to support scalability and remote access in global operations.

[0012] Further objects and advantages of the present disclosure will become apparent from the following description, which is not intended to limit the scope of the present disclosure.

[0013] The present invention relates to an AI-driven, cloud-based system for automating and optimizing real-time compliance and risk management for the biomedical and pharmaceutical industries. It integrates regulatory intelligence with operational data to ensure continuous regulatory adaptation.

[0014] Another embodiment of the present invention is the Compliance Knowledge Module, which uses AI and NLP to dynamically interpret and structure global regulations and transform them into actionable, machine-readable compliance rules linked to specific operational workflows.

[0015] Another embodiment of the present invention is the real-time monitoring module, which collects and analyzes live data from various sources - such as laboratories, production units, clinical trials, and IoT devices - to detect anomalies and early signs of non-compliance.

[0016] Another embodiment of the present invention is the Intelligent Risk Assessment Module, which uses predictive analytics and machine learning to calculate dynamic risk scores, predict compliance violations, and prioritize cross-departmental risk mitigation efforts.

[0017] Another embodiment of the present invention is the automated policy enforcement module, which initiates corrective actions when non-compliance is detected, thus ensuring traceability, auditability, and compliance with standard operating procedures (SOPs).

[0018] Another embodiment of the present invention is the dedicated Audit Readiness Module, which creates real-time compliance logs, generates reports in prescribed formats, and enables seamless virtual audits and self-assessments with advanced query tools.

[0019] Another embodiment of the present invention is the adaptive learning module, which continuously improves system intelligence through feedback loops, regulatory updates, and historical data, enabling context-aware decision making and policy adaptation.

[0020] Another embodiment of the present invention is that the invention enables a proactive, intelligent, and scalable compliance ecosystem that reduces manual effort, minimizes risk, and increases confidence in compliance across global biomedical and pharmaceutical operations.

[0021] The present invention relates to an AI-driven, cloud-based system (100) for real-time biomedical and pharmaceutical compliance and risk management based on modular components that work together to provide end-to-end regulatory monitoring, risk mitigation, and intelligent compliance automation. Each module is designed to address a specific problem area within the compliance lifecycle, ensuring seamless integration, scalability, and adaptability to changing regulations and business requirements. Compliance Knowledge Module

[0022] This module serves as the system's fundamental intelligence layer, continuously aggregating, structuring, and updating regulatory data from global sources such as the FDA, EMA, WHO, and ICH guidelines. It uses natural language processing (NLP) and AI-based rule extraction algorithms to interpret regulatory documents, convert them into machine-readable guidelines, and create dynamic compliance knowledge graphs. These graphs map relevant compliance requirements to specific biomedical and pharmaceutical processes, enabling context-aware risk assessment and audit preparation. The engine also supports version control to track regulatory changes and inform relevant stakeholders accordingly. Real-time monitoring and event recording module

[0023] This component captures and streams real-time operational data from various sources, including laboratory information management systems (LIMS), manufacturing execution systems (MES), clinical trial platforms, ERP tools, and IoT-enabled medical devices. Leveraging a scalable cloud architecture and data lake technologies, it ingests structured and unstructured data, processes it in real time, and applies AI-based anomaly detection to identify patterns that indicate potential compliance violations or risks. Integration with on-premises and third-party cloud environments ensures broad data coverage across geographically dispersed facilities. Intelligent risk assessment and prediction module

[0024] This module leverages advanced machine learning models to perform proactive risk analysis across various compliance touchpoints. It correlates live operational data with the compliance knowledge base to assign dynamic risk scores, simulate the impact of detected deviations, and predict future compliance violations. The system leverages historical violation data, root cause libraries, and supervised learning techniques to improve prediction accuracy over time. Risk dashboards and visual analytics enable regulatory and quality assurance teams to focus on high-priority threats and reduce compliance backlogs. Automated module for policy and workflow enforcement

[0025] As soon as a compliance rule or risk threshold is violated, this module automatically triggers predefined mitigation workflows tailored to the context of the event. It supports role-based access control, automatic documentation generation, electronic approvals, and, if necessary, escalations to human reviewers. Integration with digital SOP repositories ensures that the actions taken are fully traceable and compliant with internal governance protocols. This automation drastically reduces the time required to identify, address, and report compliance issues, which in turn reduces audit risk and operational downtime. Audit readiness and reporting module

[0026] This module simplifies and automates audit preparation by maintaining a continuously updated, AI-curated compliance trail. It generates real-time audit logs, compiles deviation reports, CAPA (corrective and preventive action) documents, and regulatory submissions in standardized formats. Advanced search and compliance query tools enable regulators or auditors to access specific records and evidence in seconds. This module also supports virtual audits and self-assessments by generating intelligent recommendations and compliance assessments based on historical and real-time data. Module for adaptive learning and feedback optimization

[0027] To ensure continuous improvement, this module leverages feedback loops from users, audit results, and enforcement outcomes to refine the system's AI models and policy interpretations. Reinforcement learning and model retraining routines adapt the platform to organization-specific workflows, evolving regulations, and incident patterns. Furthermore, the module enables scenario-based simulations and "what-if" analyses to assess the impact of potential changes to policies, processes, or risk thresholds. This adaptive intelligence ensures that the system remains future-proof, context-aware, and highly compliant with evolving compliance requirements.

[0028] The invention is explained again below with reference to the figure. It shows: Fig. an AI-driven, cloud-based system (100) for real-time biomedical and pharmaceutical compliance and risk management.

[0029] Fig.shows an AI-driven, cloud-based system (100) for real-time biomedical and pharmaceutical compliance and risk management. The operation of the AI-driven, cloud-based system begins with the continuous ingestion of real-time data from various biomedical and pharmaceutical sources, including clinical research systems, manufacturing processes, laboratory environments, and IoT-enabled medical devices. This data is processed by the real-time monitoring and event input module, where it is normalized and analyzed using AI algorithms to detect anomalies, operational deviations, or regulatory nonconformities. At the same time, the compliance knowledge module dynamically interprets and updates the regulatory requirements of global authorities and maps them to the company's specific operational processes.As data flows through the system, the intelligent Risk Assessment Module correlates incoming operational signals with compliance mandates, calculates risk scores, and forecasts potential violations using predictive machine learning models. When thresholds or policy violations are identified, the Automated Policy Enforcement Module activates appropriate risk mitigation workflows, notifies responsible stakeholders, and logs all actions in accordance with predefined SOPs and digital governance protocols. Meanwhile, the Audit Readiness Module creates a continuously updated compliance history in real time and generates standardized audit trails, documentation, and submission-ready reports.The adaptive learning module refines system intelligence over time by learning from past compliance events, regulatory updates, and user feedback, ensuring evolving contextual awareness and improved decision-making. All modules are orchestrated in a secure, scalable cloud environment, enabling seamless integration with global operations, remote access, and collaboration with regulators, transforming compliance from a manual, reactive function into a predictive, automated, and resilient enterprise capability.

Claims

[1] An AI-driven, cloud-based system (100) for real-time biomedical and pharmaceutical compliance and risk management, including: (a) a compliance knowledge module configured to ingest, interpret and structure regulatory data using natural language processing (NLP) and generate machine-readable compliance rules; (b) a real-time monitoring and event recording module configured to collect and normalise operational data from distributed biomedical and pharmaceutical systems, including laboratory information management systems (LIMS), manufacturing execution systems (MES) and IoT-enabled devices; (c) an intelligent risk assessment and prediction module configured to correlate operational data with compliance rules, calculate dynamic risk scores and predict potential compliance violations using machine learning models; (d) an automated policy and workflow enforcement module configured to initiate remedial actions, assign tasks and log activities based on predefined standard operating procedures (SOPs); (e) an audit readiness and reporting module configured to generate compliance logs, audit trails and standardised regulatory reports in real time; and (f) an adaptive learning and feedback optimization module configured to refine rule sets and predictive models based on feedback, historical data and regulatory updates; g) the modules are integrated into a cloud infrastructure to enable real-time, scalable and predictive compliance and risk management across biomedical and pharmaceutical processes. [2] The system (100) of claim 1, wherein the regulatory compliance knowledge module further comprises a regulatory version tracking component to monitor and alert stakeholders to updates to global regulations including FDA, EMA and GxP guidelines. [3] The system (100) of claim 1, wherein the real-time monitoring module uses stream processing to analyze time-sensitive data for anomaly detection and early warning of non-compliance. [4] The system (100) of claim 1, wherein the intelligent risk assessment module uses supervised learning and historical injury data sets to continuously improve the accuracy of the risk prediction. [5] The system (100) of claim 1, wherein the automated policy enforcement module supports electronic sign-offs, access control, and automated documentation for regulatory traceability. [6] The system (100) of claim 1, wherein the audit readiness module enables virtual audits by generating interactive compliance dashboards and exporting audit-ready documentation in prescribed formats. [7] The system (100) of claim 1, wherein the adaptive learning module performs scenario-based simulations and what-if analyses to evaluate the impact of proposed operational changes on compliance. [8] The system (100) of claim 1, wherein all modules are containerized and deployed in a multi-tenant cloud environment to support secure access, scalability, and data isolation across multiple organizational units or regions

Images